Description
LMP1 is a primary target for controlling tumorigenesis in EBV-related malignancies. The antibody exhibited a strong binding activity to the recombinant LMP1 (aa 242-328). And it is useful for attenuating LMP1 function, with potential to be developed into a control measure for LMP1-positive tumors.
Target
EBV LMP1
Target Alias Names
LMP1, Latent membrane protein 1, HHV4_LMP-1
Isotype/Mimetic
Human IgG
Animal-Derived Biomaterials Used
None
Sequence Available
No
Original Discovery Method
Human-derived phage display
Original Discovery Information Provided On Datasheet
No
Antibody/Binder Origins
Animal-free discovery, In vitro recombinant expression